ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
The Lancet Infectious Diseases
◽
10.1016/s1473-3099(20)30987-7
◽
2021
◽
Cited By ~ 11
Author(s):
Zhiwei Wu
◽
Yaling Hu
◽
Miao Xu
◽
Zhen Chen
◽
Wanqi Yang
◽
...
Keyword(s):
Clinical Trial
◽
Phase 1
◽
Healthy Adults
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Related Documents
Cited By
References
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
The Lancet Infectious Diseases
◽
10.1016/s1473-3099(20)30843-4
◽
2020
◽
Cited By ~ 11
Author(s):
Yanjun Zhang
◽
Gang Zeng
◽
Hongxing Pan
◽
Changgui Li
◽
Yaling Hu
◽
...
Keyword(s):
Clinical Trial
◽
Phase 1
◽
Healthy Adults
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Decision letter for "A Randomized Double-Blind Placebo-Controlled First-In-Human Phase 1 Trial of TransCon PTH in Healthy Adults"
10.1002/jbmr.4016/v3/decision1
◽
2020
◽
Keyword(s):
Phase 1
◽
Healthy Adults
◽
Double Blind
◽
Double Blind Placebo
◽
Phase 1 Trial
Download Full-text
Review for "A Randomized Double-Blind Placebo-Controlled First-In-Human Phase 1 Trial of TransCon PTH in Healthy Adults"
10.1002/jbmr.4016/v1/review2
◽
2019
◽
Keyword(s):
Phase 1
◽
Healthy Adults
◽
Double Blind
◽
Double Blind Placebo
◽
Phase 1 Trial
Download Full-text
Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial
The Lancet Infectious Diseases
◽
10.1016/s1473-3099(19)30614-0
◽
2020
◽
Vol 20
(4)
◽
pp. 455-466
◽
Cited By ~ 3
Author(s):
David K Clarke
◽
Rong Xu
◽
Demetrius Matassov
◽
Theresa E Latham
◽
Ayuko Ota-Setlik
◽
...
Keyword(s):
Clinical Trial
◽
Virus Vaccine
◽
Ebola Virus
◽
Phase 1
◽
Double Blind
◽
Double Blind Placebo
◽
Phase 1 Clinical Trial
Download Full-text
Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study
The Lancet Infectious Diseases
◽
10.1016/s1473-3099(15)00486-7
◽
2016
◽
Vol 16
(3)
◽
pp. 311-320
◽
Cited By ~ 94
Author(s):
Olga De Santis
◽
Régine Audran
◽
Emilie Pothin
◽
Loane Warpelin-Decrausaz
◽
Laure Vallotton
◽
...
Keyword(s):
Phase 1
◽
Healthy Adults
◽
Dose Finding
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Jakyakgamcho-tang in the relief of delayed-onset muscle soreness in healthy adults: study protocol for a randomized, double-blind, placebo-controlled, crossover design clinical trial
Trials
◽
10.1186/s13063-020-4119-4
◽
2020
◽
Vol 21
(1)
◽
Author(s):
Kyungsun Han
◽
Ojin Kwon
◽
So-Young Jung
◽
In-hwa Park
◽
Man-Suk Hwang
◽
...
Keyword(s):
Clinical Trial
◽
Study Protocol
◽
Muscle Soreness
◽
Delayed Onset Muscle Soreness
◽
Crossover Design
◽
Healthy Adults
◽
Double Blind
◽
Double Blind Placebo
◽
Delayed Onset
Download Full-text
Safety, tolerability and pharmacodynamics of AZP-3601, a novel long-acting PTH analog, in healthy adults: Data from a randomized, double-blind, placebo-controlled phase 1 study
Endocrine Abstracts
◽
10.1530/endoabs.73.oc6.5
◽
2021
◽
Author(s):
Soraya Allas
◽
Michel Ovize
◽
Michael D. Culler
◽
Clarisse Geraul
◽
van de Wetering Jeroen
◽
...
Keyword(s):
Phase 1
◽
Healthy Adults
◽
Phase 1 Study
◽
Double Blind
◽
Double Blind Placebo
◽
Long Acting
Download Full-text
Safety, tolerability, and preliminary immunogenicity of a recombinant Staphylococcus aureus vaccine (RSAV) in healthy adults between 18 and 65 years in China: study protocol for a randomized, double-blind, placebo-controlled, phase 1 trial
Journal of Public Health and Emergency
◽
10.21037/jphe.2016.12.11
◽
2017
◽
Vol 1
◽
pp. 25-25
Author(s):
Yuan-Yuan Zhu
◽
Jing-Xin Li
◽
Hao Zeng
◽
Ming Zeng
◽
Fan-Yue Meng
◽
...
Keyword(s):
Staphylococcus Aureus
◽
Study Protocol
◽
Phase 1
◽
Healthy Adults
◽
Double Blind
◽
Double Blind Placebo
◽
Phase 1 Trial
◽
China Study
Download Full-text
A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis
BMC Pharmacology and Toxicology
◽
10.1186/s40360-018-0200-y
◽
2018
◽
Vol 19
(1)
◽
Cited By ~ 13
Author(s):
Melissa Palmer
◽
Lee Jennings
◽
Debra G. Silberg
◽
Caleb Bliss
◽
Patrick Martin
Keyword(s):
Phase 1
◽
Healthy Adults
◽
Phase 1 Study
◽
Double Blind
◽
Double Blind Placebo
◽
Alcoholic Steatohepatitis
Download Full-text
H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial
The Lancet Infectious Diseases
◽
10.1016/s1473-3099(15)00378-3
◽
2016
◽
Vol 16
(3)
◽
pp. 303-310
◽
Cited By ~ 21
Author(s):
Larisa Rudenko
◽
Irina Isakova-Sivak
◽
Anatoly Naykhin
◽
Irina Kiseleva
◽
Marina Stukova
◽
...
Keyword(s):
Influenza Vaccine
◽
Phase 1
◽
Healthy Adults
◽
Double Blind
◽
Double Blind Placebo
◽
Phase 1 Trial
◽
Live Attenuated Influenza Vaccine
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close